ProMedTours > MEDICAL NEWS
 

Medical News

J&J Pulls Baby Powder From Market

]]>(MedPage Today) -- WASHINGTON -- Johnson & Johnson is recalling one lot of its famous baby powder because of possible asbestos contamination, the FDA announced Friday. "FDA testing has found that a sample from one lot of the product contains...

FDA OKs First Tx for Rare Disease That Makes Light Painful

]]>(MedPage Today) -- The FDA approved the first treatment, afamelanotide (Scenesse), for rare phototoxic disorder erythropoietic protoporphyria. Afemelanotide, an melanocortin-1 receptor agonist, is indicated to increase pain-free light exposure...

The FDA Database Where a Death Isn't a 'Death'

]]>(MedPage Today) -- Many patient deaths may go uncounted by taking the FDA's Manufacturer and User Facility Device Experience (MAUDE) database at face value, researchers found. A close look at the publicly available postmarketing medical device...

Canagliflozin OK'd for Preventing HF Hospitalization in T2D

]]>(MedPage Today) -- WASHINGTON -- In another label expansion, the FDA approved new cardiovascular and renal prevention indications for canagliflozin (Invokana), according to a statement from the Janssen unit of Johnson & Johnson. The SGLT...

Zantac Generic Pulled From Markets Worldwide

]]>(MedPage Today) -- One manufacturer of generic ranitidine (Zantac), Novartis's Sandoz unit, has reportedly decided to halt distribution of the antacid drug until a contamination issue is resolved. Last week, the FDA said some lots of ranitidine...

FDA: Nitrosamines Found in New Class of Meds

]]>(MedPage Today) -- WASHINGTON -- Some lots of the antacid drug ranitidine (Zantac) were found to contain small amounts of N-nitrosodimethylamine (NDMA), the FDA said Friday morning. NDMA is one of the potentially carcinogenic chemicals that...

Second-Hand Vaping; PTSD and Ovarian Cancer; Un-Real-World Cancer Studies?

]]>(MedPage Today) -- One third of middle- and high-school students reported exposure to second-hand vaping aerosol in public places. (CNN) AbbVie will discontinue development of rovalpituzumab tesirine (Rova-T) after a phase III clinical trial failed...

CDC Warns Against Use of Black Market E-Cigarettes

]]>(MedPage Today) -- Following growing numbers of reports of respiratory illness -- totaling 215 at last count -- and one death thought to be linked to vaping, the CDC on Friday warned e-cigarette users to avoid purchasing black market cannabis...

Burst Balloons Force TAVR Device Recall

]]>(MedPage Today) -- Just days after expanding the indication for Edwards Lifesciences' Sapien 3 and other transcatheter aortic valve replacement (TAVR) devices, the FDA announced a Class I recall on the Sapien 3 Ultra delivery system. The recall...

Morning Break: Canada Balks at Drug Exports; Heat Wave Threat; Opioid 'Villains'

]]>(MedPage Today) -- Note that some links may require subscriptions. Proposals to import drugs from Canada face opposition from a crucial stakeholder: Canada. (Reuters) With a massive heatwave baking much of the U.S., the American Heart Association...